PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast

By PVI, PeerView Institute for Medical Education

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

  1. 1.
    Donna H. Ryan, MD, FTOS -Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
  2. 2.
    Bruce R. Korf, MD, PhD / Nicole J. Ullrich, MD, PhD, MMSci - Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
  3. 3.
    R. Robert Auger, MD, FAASM, FAPA, DABPN - The Dawn of a New Era: Recent Advances in the Pharmacologic Management of Idiopathic Hypersomnia
  4. 4.
    Loren D.M. Pena, MD, PhD - Advancing the Treatment of Pompe Disease: Clinical Updates in Newborn Screening and Enzyme Replacement
  5. 5.
    Stuart H. Isaacson, MD - Managing Motor Complications in Parkinson’s Disease: Evaluating the Role of On-Demand Therapies for “Off” Episodes
  6. 6.
    Jinsy A. Andrews, MD, MSc, FAAN - A Visual Exploration of Antisense Oligonucleotide Therapies in Amyotrophic Lateral Sclerosis
  7. 7.
    Richard K. Bogan, MD, FCCP, FAASM - The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
  8. 8.
    Amit Bar-Or, MD, FRCPC / Ludwig Kappos, MD, FEAN, FAAN - The Rise of B-Cell Therapies in Relapsing MS: Examining the State of the Science, New Therapeutic Options, and Patient-Centered Clinical Decision-Making
  1. 9.
    Elizabeth A. Thiele, MD, PhD - Applying Evidence to Practice: Updated Consensus Recommendations for the Diagnosis, Surveillance, and Management of Tuberous Sclerosis Complex
  2. 10.
    Benjamin W. Friedman, MD, MS, FAAEM, FACEP, FAHS - A New Era of Migraine Management: Recent Updates on Recognition, Acute Treatment, and Prevention for Emergency Physicians
  3. 11.
    Crystal M. Proud, MD - Data-Based Updates: Practical Application of Recent Evidence on Disease-Modifying Therapies for SMA
  4. 12.
    Karl E. Anderson, MD - Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
  5. 13.
    Edward J. Fox, MD, PhD - A Visual Guide to B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment Landscape
  6. 14.
    Marwan Sabbagh, MD, FAAN, CCRI - Expert Perspectives on the Early Diagnosis of Alzheimer’s Disease and the Promise of Novel Therapies on the Horizon
  7. 15.
    Kristina M. Deligiannidis, MD - Test Your Knowledge: The Evidence for GABA-Modulating Neuroactive Steroids as a New Class of Rapid-Acting Antidepressants
  8. 16.
    Anne H. Cross, MD, FAAN / Prof. Xavier Montalban - Exploring the Rationale, Results, and Real-World Clinical Potential of BTK Inhibitors in the Management of Multiple Sclerosis
  9. 17.
    Steven Brem, MD - Rethinking Glioblastoma Care in an Evolving Therapeutic Landscape: Expert Perspectives on Modern Modalities, Novel Agents, and Combinations
  10. 18.
    Maria K. Houtchens, MD, MMs - MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies
  11. 19.
    John Ravits, MD - Improving Outcomes in ALS Through Early Diagnosis and Emerging Targeted Therapies
  12. 20.
    Bruce Cree, MD, PhD, MAS - Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
  13. 21.
    Orrin Devinsky, MD - Cannabidiol in the Treatment Arsenal for Severe Epilepsy Syndromes: Practical Guidance for Managed Care Professionals
  14. 22.
    Prof. Xavier Montalban - What’s New in Relapsing MS? Expert Perspectives on Pathogenesis, Targeting B Cells for Treatment, and Advances in Disease-State Monitoring
  15. 23.
    Amit Bar-Or, MD, FRCPC / Bruce Cree, MD, PhD, MAS - Realizing the Full Clinical Potential of Sphingosine-1-Phosphate Receptor Modulation to Improve Outcomes in Patients With Multiple Sclerosi
  16. 24.
    Peter Goadsby, MD, PhD - Addressing Unmet Needs in the Acute Treatment of Migraine: Focus on the Role of the 5-HT1F Receptor
  17. 25.
    Karen Elta Anderson, MD - Finding the Path to Improved Recognition and Management of Tardive Dyskinesia
  18. 26.
    Marwan Sabbagh, MD, FAAN, CCRI - Exploring Current Guidelines and Emerging Therapeutic Strategies for the Treatment of Dementia-Related Psychosis
  19. 27.
    Perry Shieh, MD, PhD, FAAN - Ensuring Optimal Management Throughout the Clinical Spectrum of Spinal Muscular Atrophy
  20. 28.
    Victor C. Urrutia, MD, FAHA - Time Is of The Essence: Incorporating Recent Guideline Updates to Support Early Recognition and Management of Acute Ischemic Stroke
  21. 29.
    Gregory W. Albers, MD - Large Hemispheric Infarction: Exploring the Latest Clinical Advances in the Diagnosis and Treatment
  22. 30.
    Diana Castro, MD - Great Expectations: Helping Patients With Spinal Muscular Atrophy and Their Families Understand Diagnosis and Treatment in a New Era of Therapy
  23. 31.
    Stephen Krieger, MD, FAAN / Clyde E. Markowitz, MD - Navigating the Evolving Management Paradigm Across Multiple Sclerosis Phenotypes in the Age of Potential Prognostic and Predictive Biomarkers
  24. 32.
    "Brenda L. Banwell, MD, FAAP, FRCPC, FAAN - Addressing Barriers to the Ready Recognition and Timely Treatment of Pediatric Multiple Sclerosis"
  25. 33.
    Diana Castro, MD - Altering the Natural History of Spinal Muscular Atrophy: A Compelling Story Highlighting the Critical Role of Presymptomatic Treatment
  26. 34.
    Edward J. Fox, MD, PhD - Current Status and Future Directions in the Treatment of Multiple Sclerosis: What Are the Key Learnings From Stockholm?
  27. 35.
    Steven Brem, MD - Brainstorming Personalized Care Strategies in Glioblastoma: Rethinking and Refining Therapeutic Algorithms With Tumor Treating Fields and Novel Systemic Approaches
  28. 36.
    Matthew T. Ballo, MD, FACR - Readying the Modern Radiation Oncology Practice for Incorporation of a Fourth Modality in Cancer Treatment: Understanding the Science, Evidence & Clinical Application Across a Range of Solid Malignancies
  29. 37.
    Joshua D. Lee, MD, MSc - Caring for the Patient With Opioid Use Disorder in an Outpatient Setting: Overcoming the Barriers to Medication-Assisted Treatment
  30. 38.
    Joseph I. Sirven, MD - Generalized Tonic-Clonic Seizures: Clinical Pearls for Recognition and Optimal Management
  31. 39.
    Michael Polydefkis, MD - Clinical Pearls for the Accurate Diagnosis and Optimal Treatment of Hereditary ATTR Amyloidosis
  32. 40.
    Bruce Cree, MD, PhD, MAS - Examining Late-Breaking Data on Disease-Modifying Therapies for the Treatment of Multiple Sclerosis — An Update From Philadelphia
  33. 41.
    Edward J. Fox, MD, PhD - Personalizing Disease-Modifying Therapy for Multiple Sclerosis in the Era of Expanding Treatment Options and Potential Biomarkers
  34. 42.
    Adam Boxer, MD - Progressive Supranuclear Palsy: Examining Diagnostic Considerations and Emerging Treatment Approaches
  35. 43.
    Jerry Vockley, MD, PhD - Diminishing the Burden of Phenylketonuria During Adulthood: New Science & Encouraging Stories Highlighting the Critical Role of Adjunctive Therapy in Alleviating Neurocognitive Symptoms and Easing Dietary Constraints
  36. 44.
    Kevin N. Sheth, MD - Exploring Unmet Needs in Large Hemispheric Infarction: Clinical Insights on Early Recognition and Emerging Therapy
  37. 45.
    Stewart J. Tepper, MD, FAHS - Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention
  38. 46.
    Anup D. Patel, MD, FAAN - Harnessing the Full Potential of Available Therapies for the Treatment of Lennox-Gastaut Syndrome: A Story Behind the Science
  39. 47.
    Aaron Boster, MD - Improving Outcomes in Multiple Sclerosis Through the Practice of Shared Decision-Making in Disease-Modifying Therapy Selection
  40. 48.
    Marwan Sabbagh, MD, FAAN - Taking Stock of Potential Advances in the Early Diagnosis of Alzheimer’s Disease: What Are the Implications for Treatment?
  41. 49.
    Barry Singer, MD - Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin?
  42. 50.
    Richard S. Finkel, MD - Breaking Down the Barriers to Optimal Spinal Muscular Atrophy Care: Overcoming Diagnostic Delays, Facilitating Early Treatment, and Easing Caregiver Burden

Listen to PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast now.

Listen to PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast in full in the Spotify app